PreludeDx Presents New Data Demonstrating Utility of DCISionRT to De-escalate Radiation Therapy for Women with DCIS itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in precision diagnostics for early-stage breast cancer, presented data on the use of DCISionRT® to.